Home » Topics » BioWorld Science

BioWorld Science
RSS

Hepsin contributes to metastasis and thrombosis in patients with CRC, study finds

July 20, 2022

Novel HDAC3 inhibitor shows antitumor activity in 4T1-Luc xenograft mouse model

July 19, 2022

Researchers unveil novel markers involved in pulmonary embolism

July 19, 2022

Organoid efficacy data leads to approval of clinical trial of rare disease drug

July 19, 2022

Targeting GABA-transported GAT-3 in astrocytes reduces negative outcomes of brain injury

July 19, 2022

Chinese researchers synthesize new vasopressin receptor antagonists

July 19, 2022

Jiangsu Tasly Diyi Pharmaceutical presents new FXR agonists

July 19, 2022

Abbisko Therapeutics describes new GTPase KRAS inhibitors

July 19, 2022

Inventiosbio discloses new TYK2 inhibitors

July 19, 2022

Medshine Discovery patents IRAK4 and BTK inhibitors

July 19, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...